The best academic award in the vaccines field over the last 12 months is awarded to a researcher or academic institution that has made significant contributions to the development, understanding, or improvement of vaccines. The recipient of this award has demonstrated excellence in research, innovation, and impact in the field of vaccines. Their work has advanced the scientific knowledge and practical application of vaccines, leading to potential improvements in public health and disease prevention. The recipient has also shown leadership and collaboration within the academic community, contributing to the overall advancement of the vaccines field. This award recognizes and celebrates the outstanding achievements and contributions of the recipient to the field of vaccines.

The Best Biotech Award recognizes companies or individuals who have demonstrated outstanding thought leadership in spearheading innovation within the biotech industry. This includes a commitment to providing platforms or technologies to develop vaccines for unmet medical needs. The award also considers the solutions the technology or platform offers to vaccine developers, particularly in comparison to existing technologies. Additionally, progress towards specific vaccines, whether developed in-house or indirectly through partnerships or clients, is taken into account. Overall, the award recognizes and celebrates those who are making significant contributions to the advancement of biotechnology and the development of life-saving vaccines.

The Best Central / Specialty Laboratory Award recognizes laboratories that provide a wide range of clinical and specialty lab services in support of vaccine development. These services play a crucial role in successfully completing vaccine studies by offering expertise in areas such as immunology, virology, and molecular biology. Whether providing full service support or niche services, these labs contribute to the development and testing of vaccines by offering accurate and reliable analysis of samples, ensuring compliance with regulatory requirements, and delivering timely results. Recognition as a central vaccine lab is achieved through milestones such as successful completion of clinical trials, publication of research findings, and ongoing outcomes such as the approval and distribution of vaccines. These achievements demonstrate the impact and contribution of the lab to the advancement of vaccine development.

The Best Clinical Trial Company Award recognizes companies that excel in meeting clinical development needs through a comprehensive programmatic assessment. This includes supporting multiple and diverse clinical phase and outcomes trials for vaccines, as well as implementing methods for performance improvement and introducing new services. The award also considers companies that demonstrate rapid enrollment across a range of vaccines and exceptional study subject retention. Additionally, reaching milestones and achieving final or ongoing outcomes/trials is a key factor in determining the recipient of this award.

The Best Clinical Trial Network Award recognizes networks that excel in delivering high quality data and predictable enrollment for clinical trials. They are supportive of multiple and diverse clinical phase and outcomes trials for vaccines, and demonstrate methods of performance improvement or introduction of new services across the network. These networks offer improved efficiencies while maintaining exceptional quality and industry professionals. They also demonstrate success in reaching milestones and achieving final or ongoing outcomes in clinical trials.

The Best Contract Manufacturing Organization Award recognizes companies that excel in providing a wide range of services in both niche and core therapeutic areas. This includes the ability to consistently improve performance and introduce new services to meet the evolving needs of clients. The award also considers the quality of relationships with clients, as well as the ability to reach milestones and deliver successful outcomes. Additionally, the award recognizes the ability to build and maintain long-term partnerships with clients, demonstrating a commitment to ongoing collaboration and success.

The Best Contract Research Award recognizes contract research organizations that excel in providing a wide range of services in both niche and core therapeutic areas. The award also considers the methods used to improve performance or introduce new services, as well as the quality of relationships with clients. Additionally, the award takes into account the organization's ability to reach milestones and achieve final or ongoing outcomes, as well as their success in building and maintaining long-term partnerships with clients.

The Best Pharma Company Award recognizes pharmaceutical companies with a significant and diverse vaccine pipeline. This includes a mix of candidates in various stages of development, from early research to late-stage clinical trials. The award also considers the company's commitment to innovation and the development of lower risk vaccine candidates. Additionally, the company's dedication to implementing a productive research and development model is taken into account. Finally, the award evaluates the current and future market potential and value of the company's vaccine pipeline.

The Best Production/Process Development Award recognizes companies that show a continuous dedication to providing production or process technology globally and in reducing lead times for their customers. This includes offering end-to-end solutions to customers, showing outstanding thought leadership in spearheading innovation, and raising the bar of process or production standards. Additionally, the award also considers the attention to and quality of relationships with clients.

The Best Prophylactic Vaccine Award recognizes candidates that address current unmet medical needs, have significant potential for vast geographical and market reach, possess a novel mode of action or technology, have made progress through clinical trials and achieved milestones, and have strong safety and risk management data. This award aims to highlight and honor prophylactic vaccines that have the potential to make a significant impact on public health and disease prevention.

The Best Therapeutic Vaccine Award recognizes candidates that address current unmet medical needs, have significant potential for vast geographical and market reach, possess a novel mode of action or technology, have made progress through clinical trials and achieved milestones, and have strong safety and risk management data. This award highlights therapeutic vaccines that have the potential to make a significant impact on global health by addressing unmet medical needs and utilizing innovative technology.

The Vaccine Advocate of the Year Award recognizes individuals who have demonstrated exceptional commitment and leadership in promoting immunizations within their community. Nominees are evaluated based on their community expertise, such as serving as a spokesperson or educator to encourage adoption of immunizations. They are also assessed on their advocacy efforts, including their work to implement and improve policies and legislation to support immunization in their state or region, such as through legislative testimony and media appearances. Additionally, nominees are evaluated on their collaborations and partnerships with other advocates and organizations to collectively address complex problems related to immunization. Finally, the award recognizes nominees who have contributed to the development of innovative strategies to improve access and uptake of vaccines in underserved communities throughout the vaccine life cycle.